Benzinga | Jan 7, 2021 06:20AM EST

Wells Fargo Initiates Coverage On Arcturus Therapeutics with Overweight Rating

Wells Fargo initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Overweight rating.